Insulin aspart, recombinant Subcutaneous and Laronidase Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Laronidase Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: laronidase
Brand name: Aldurazyme
Synonyms: Laronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Larotrectinib
- Insulin aspart, recombinant Subcutaneous-Larotrectinib Capsules
- Insulin aspart, recombinant Subcutaneous-Larotrectinib Oral Solution
- Insulin aspart, recombinant Subcutaneous-Larotrectinib Sulfate
- Insulin aspart, recombinant Subcutaneous-Lartruvo
- Insulin aspart, recombinant Subcutaneous-Larynex
- Laronidase Intravenous-Insulin degludec
- Laronidase Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Laronidase Intravenous-Insulin Degludec (U-100) Vials
- Laronidase Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Laronidase Intravenous-Insulin degludec and liraglutide
- Laronidase Intravenous-Insulin degludec and liraglutide Subcutaneous